Medical cannabis · healthcare market
A market driven by prescription, not by trends.
The healthcare market for medical cannabis is growing through indication expansion, reimbursement decisions and increasing willingness to prescribe, not through advertising.
01Market data
What defines the market.
~10,000 patients CH
Currently under prescription, with a growth trend.
CHF 80–120M
Swiss market potential by 2030.
Indications
Pain, spasticity, oncology supportive therapy, sleep.
02Drivers
Structural, not cyclical, growth.
- Government reimbursement in several EU countries.
- Growing real-world evidence base.
- Training initiatives for physicians.
- Integration into specialist clinics and pain centres.
Contact
Let's talk aboutCollaboration.
Whether market access, manufacturing, white label, technology or strategic partnership: speak with our team about joint projects in regulated markets.
Partnershipsinfo@heimatmanufaktur.ch
HeadquartersSteinach, Switzerland